April 2, 2018 / 8:09 PM / in 18 days

Allergan seeks options for women's health unit: Bloomberg

(Reuters) - Allergan Plc is considering options for its women’s health unit, including a sale, Bloomberg reported on Monday, citing people with knowledge of the matter.

FILE PHOTO: The Allergan logo is seen in this photo illustration in Singapore November 23, 2015. REUTERS/Thomas White/File Photo

A sale, which would likely attract interest from private equity firms, could value the business at more than $5 billion, according to the Bloomberg report.

The women’s health unit, which makes oral contraceptive pills to menopause treatment, raked in $1.04 billion sales in 2017.

A decision on whether to pursue a sale hasn’t been made and the Botox maker could choose to keep the business, Bloomberg reported. An Allergan spokeswoman declined to comment.

The company’s shares closed at $162.27, and have fallen about 34 percent in the last twelve months.

Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Shounak Dasgupta

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below